Characterization and Modulation of Mucosal Immunity for HIV Prevention in Women
Status:
Terminated
Trial end date:
2016-10-28
Target enrollment:
Participant gender:
Summary
This study seeks to understand the immune cells in the cervical fluid of in the blood and
genital tract of HIV-negative healthy female volunteers and to see if these cells can be
modified using a combined anti-viral and antiinflammatory drug called maraviroc, a medicine
used in the treatment of HIV infection.
Phase:
N/A
Details
Lead Sponsor:
Emory University
Treatments:
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination Maraviroc